Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors

Gene Therapy volume 13, pages 715–724 (2006)Cite this article

Abstract

Lentivirus-based gene transfer has the potential to efficiently deliver DNA-based therapies into non-dividing epithelial cells of the airway for the treatment of lung diseases such as cystic fibrosis. However, significant barriers both to lung-specific gene transfer and to production of lentivirus vectors must be overcome before these vectors can be routinely used for applications to the lung. In this study, we investigated whether the ability to produce lentiviral vectors pseudotyped with fowl plague virus hemagglutinin (HA) could be improved by co-expression of influenza virus M2 in vector-producing cells. We found that M2 expression led to a 10–30-fold increase in production of HA-pseudotyped lentivirus vectors based upon equine infectious anemia virus (EIAV) or human immunodeficiency virus type 1 (HIV-1). Experiments using the M2 inhibitor amantadine and a drug-resistant mutant of M2 established that the ion channel activity of M2 was important for M2-dependent augmentation of vector production. Furthermore, the neuraminidase activity necessary for particle release from producer cells could also be incorporated into producer cells by co-expression of influenza NA cDNA. Lentiviral vectors pseudotyped with influenza envelope proteins were able to efficiently transduce via the apical membrane of polarized mouse tracheal cultures in vitro as well as mouse tracheal epithelia in vivo.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Emi N, Friedmann T, Yee JK . Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 1991; 65: 1202–1207.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–267.

    Article  CAS  PubMed  Google Scholar 

  3. O'Rourke JP, Hiraragi H, Urban K, Patel M, Olsen JC, Bunnell BA . Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors. Mol Ther 2003; 7: 632–639.

    Article  CAS  PubMed  Google Scholar 

  4. Goldman MJ, Lee PS, Yang JS, Wilson JM . Lentiviral vectors for gene therapy of cystic fibrosis. Hum Gene Ther 1997; 8: 2261–2268.

    Article  CAS  PubMed  Google Scholar 

  5. Johnson LG, Mewshaw JP, Ni H, Friedmann T, Boucher RC, Olsen JC . Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol 1998; 72: 8861–8872.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Wang G, Slepushkin V, Zabner J, Keshavjee S, Johnston JC, Sauter SL et al. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest 1999; 104: R55–R62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Johnson LG, Olsen JC, Naldini L, Boucher RC . Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Therapy 2000; 7: 568–574.

    Article  CAS  PubMed  Google Scholar 

  8. Kobinger GP, Weiner DJ, Yu QC, Wilson JM . Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol 2001; 19: 225–230.

    Article  CAS  PubMed  Google Scholar 

  9. Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL et al. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 2003; 77: 5902–5910.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Medina MF, Kobinger GP, Rux J, Gasmi M, Looney DJ, Bates P et al. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 2003; 8: 777–789.

    Article  PubMed  Google Scholar 

  11. Kobayashi M, Iida A, Ueda Y, Hasegawa M . Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J Virol 2003; 77: 2607–2614.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hatziioannou T, Valsesia-Wittmann S, Russell SJ, Cosset FL . Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J Virol 1998; 72: 5313–5317.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Bosch V, Kramer B, Pfeiffer T, Starck L, Steinhauer DA . Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors. J Gen Virol 2001; 82: 2485–2494.

    Article  CAS  PubMed  Google Scholar 

  14. Sandrin V, Boson B, Salmon P, Gay W, Negre D, Le Grand R et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002; 100: 823–832.

    Article  CAS  PubMed  Google Scholar 

  15. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC . Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 1983; 304: 76–78.

    Article  CAS  PubMed  Google Scholar 

  16. Wharton SA, Calder LJ, Ruigrok RW, Skehel JJ, Steinhauer DA, Wiley DC . Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J 1995; 14: 240–246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Cross KJ, Wharton SA, Skehel JJ, Wiley DC, Steinhauer DA . Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J 2001; 20: 4432–4442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC, Hay AJ . Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci USA 1991; 88: 11525–11529.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bron R, Kendal AP, Klenk HD, Wilschut J . Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics. Virology 1993; 195: 808–811.

    Article  CAS  PubMed  Google Scholar 

  20. Palese P, Compans RW . Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 1976; 33: 159–163.

    Article  CAS  PubMed  Google Scholar 

  21. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD . Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 2004; 78: 12665–12667.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Griffin JA, Basak S, Compans RW . Effects of hexose starvation and the role of sialic acid in influenza virus release. Virology 1983; 125: 324–334.

    Article  CAS  PubMed  Google Scholar 

  23. Wang C, Takeuchi K, Pinto LH, Lamb RA . Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol 1993; 67: 5585–5594.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Neumayer EM, Haff RF, Hoffman CE . Antiviral Activity of amantadine hydrochloride in tissue culture and in ovo. Proc Soc Exp Biol Med 1965; 119: 393–396.

    Article  CAS  PubMed  Google Scholar 

  25. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH . The molecular basis of the specific anti-influenza action of amantadine. EMBO J 1985; 4: 3021–3024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Bayle JY, Johnson LG, St George JA, Boucher RC, Olsen JC . High-efficiency gene transfer to primary monkey airway epithelial cells with retrovirus vectors using the gibbon ape leukemia virus receptor. Hum Gene Ther 1993; 4: 161–170.

    Article  CAS  PubMed  Google Scholar 

  27. Ostrowski LE, Hutchins JR, Zakel K, O'Neal WK . Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter. Mol Ther 2003; 8: 637–645.

    Article  CAS  PubMed  Google Scholar 

  28. Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 2005; 79: 1113–1124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ohuchi M, Cramer A, Vey M, Ohuchi R, Garten W, Klenk HD . Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol 1994; 68: 920–926.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Wharton SA, Belshe RB, Skehel JJ, Hay AJ . Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J Gen Virol 1994; 75 (Part 4): 945–948.

    Article  CAS  PubMed  Google Scholar 

  31. Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, Brownlee G et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 2003; 305: 192–200.

    Article  CAS  PubMed  Google Scholar 

  32. Voeten JT, Brands R, Palache AM, van Scharrenburg GJ, Rimmelzwaan GF, Osterhaus AD et al. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 1999; 17: 1942–1950.

    Article  CAS  PubMed  Google Scholar 

  33. Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001; 10: 2109–2121.

    Article  CAS  PubMed  Google Scholar 

  34. Wong LF, Azzouz M, Walmsley LE, Askham Z, Wilkes FJ, Mitrophanous KA et al. Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol Ther 2004; 9: 101–111.

    Article  CAS  PubMed  Google Scholar 

  35. You Y, Richer EJ, Huang T, Brody SL . Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1315–L1321.

    Article  CAS  PubMed  Google Scholar 

  36. Forger III JM, Bronson RT, Huang AS, Reiss CS . Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system. J Virol 1991; 65: 4950–4958.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD . Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004; 101: 4620–4624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Limberis M, Anson DS, Fuller M, Parsons DW . Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum Gene Ther 2002; 13: 1961–1970.

    Article  CAS  PubMed  Google Scholar 

  39. Olsen JC, Swanstrom R . A new pathway in the generation of defective retrovirus DNA. J Virol 1985; 56: 779–789.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Olsen JC, Johnson LG, Stutts MJ, Sarkadi B, Yankaskas JR, Swanstrom R et al. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum Gene Ther 1992; 3: 253–266.

    Article  CAS  PubMed  Google Scholar 

  41. Henkel JR, Weisz OA . Influenza virus M2 protein slows traffic along the secretory pathway. pH perturbation of acidified compartments affects early Golgi transport steps. J Biol Chem 1998; 273: 6518–6524.

    Article  CAS  PubMed  Google Scholar 

  42. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR . Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989; 77: 51–59.

    Article  CAS  PubMed  Google Scholar 

  43. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR . Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001; 146: 2275–2289.

    Article  CAS  PubMed  Google Scholar 

  44. Olsen JC . Gene transfer vectors derived from equine infectious anemia virus. Gene Therapy 1998; 5: 1481–1487.

    Article  CAS  PubMed  Google Scholar 

  45. Olsen JC, Sechelski J . Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum Gene Ther 1995; 6: 1195–1202.

    Article  CAS  PubMed  Google Scholar 

  46. Engelhardt JF, Allen ED, Wilson JM . Reconstitution of tracheal grafts with a genetically modified epithelium. Proc Natl Acad Sci USA 1991; 88: 11192–11196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Institutes of Health HL 51818 and HL 66943 and sponsored research funds from Oxford BioMedica, Ltd (Oxford, UK). The FPV-HA expression plasmid was a kind gift from Dr Francois-Loic Cosset (Laboratoire de Vectorologie Retrovirale et Therapie Genique, Lyon, France). The plasmid encoding FPV M2 was a kind gift from Dr Ora Weisz (Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA). We thank John B Sechelski and Miriam Vanhook for excellent technical assistance. We are also grateful to Kimberlie Burns and Elizabeth Andrews for assistance in preparing tissue sections.

Author information

Authors and Affiliations

  1. Department of Medicine, Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    T McKay, M Patel, R J Pickles, L G Johnson & J C Olsen

Authors
  1. T McKay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R J Pickles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L G Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J C Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J C Olsen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKay, T., Patel, M., Pickles, R. et al. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 13, 715–724 (2006). https://doi.org/10.1038/sj.gt.3302715

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302715

Keywords

This article is cited by

Search

Advanced search

Quick links